Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 CPS1 DNAH7 RYR3 DST PCDHGA12 PCDHGA8	1.05e-06	749	113	17	GO:0005509
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	3.58e-11	187	114	13	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	1.94e-08	313	114	13	GO:0098742
MousePheno	abnormal retina blood vessel morphology	IFI27L2 FOXN2 IFI27L1 DST BRD4 SYNE2 UGT2B15 UGT2B17 PEAK1	6.58e-06	234	79	9	MP:0010097
MousePheno	persistence of hyaloid vascular system	FOXN2 ANGPT2 RXFP3 CASZ1 DST UGT2B15 UGT2B17 PDZRN3	3.65e-05	223	79	8	MP:0001289
MousePheno	abnormal retina vasculature morphology	IFI27L2 FOXN2 ANGPT2 IFI27L1 DST BRD4 SYNE2 UGT2B15 UGT2B17 PEAK1	6.59e-05	390	79	10	MP:0002792
MousePheno	delayed CNS synapse formation	SYN1 SYN2	9.43e-05	3	79	2	MP:0002924
MousePheno	abnormal eye vasculature morphology	IFI27L2 FOXN2 ANGPT2 IFI27L1 DST BRD4 SYNE2 UGT2B15 UGT2B17 PEAK1	1.10e-04	415	79	10	MP:0031346
Domain	Cadherin_tail	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	2.00e-20	37	112	13	PF15974
Domain	Cadherin_CBD	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	2.00e-20	37	112	13	IPR031904
Domain	Cadherin_C	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	1.40e-19	42	112	13	IPR032455
Domain	Cadherin_C_2	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	1.40e-19	42	112	13	PF16492
Domain	Cadherin_2	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	8.02e-17	65	112	13	PF08266
Domain	Cadherin_N	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	8.02e-17	65	112	13	IPR013164
Domain	Cadherin_CS	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	9.18e-14	109	112	13	IPR020894
Domain	CADHERIN_1	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	1.48e-13	113	112	13	PS00232
Domain	Cadherin	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	1.48e-13	113	112	13	PF00028
Domain	CADHERIN_2	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	1.66e-13	114	112	13	PS50268
Domain	-	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	1.66e-13	114	112	13	2.60.40.60
Domain	CA	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	1.86e-13	115	112	13	SM00112
Domain	Cadherin-like	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	2.09e-13	116	112	13	IPR015919
Domain	Cadherin	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	2.61e-13	118	112	13	IPR002126
Domain	TEA_1	TEAD1 TEAD4 TEAD3	8.36e-07	4	112	3	PS00554
Domain	TEA	TEAD1 TEAD4 TEAD3	8.36e-07	4	112	3	SM00426
Domain	Ifi-6-16	IFI27L2 IFI27 IFI27L1	8.36e-07	4	112	3	PF06140
Domain	IFI6/IFI27	IFI27L2 IFI27 IFI27L1	8.36e-07	4	112	3	IPR009311
Domain	TEA_2	TEAD1 TEAD4 TEAD3	8.36e-07	4	112	3	PS51088
Domain	TEA	TEAD1 TEAD4 TEAD3	8.36e-07	4	112	3	PF01285
Domain	TEA/ATTS_dom	TEAD1 TEAD4 TEAD3	8.36e-07	4	112	3	IPR000818
Domain	TEF_metazoa	TEAD1 TEAD4 TEAD3	8.36e-07	4	112	3	IPR016361
Domain	PH-BEACH_dom	NBEAL1 LYST NSMAF	1.15e-05	8	112	3	IPR023362
Domain	-	NBEAL1 LYST NSMAF	1.15e-05	8	112	3	2.30.29.40
Domain	PH_BEACH	NBEAL1 LYST NSMAF	1.15e-05	8	112	3	PS51783
Domain	BEACH_dom	NBEAL1 LYST NSMAF	1.72e-05	9	112	3	IPR000409
Domain	BEACH	NBEAL1 LYST NSMAF	1.72e-05	9	112	3	PS50197
Domain	Beach	NBEAL1 LYST NSMAF	1.72e-05	9	112	3	PF02138
Domain	-	NBEAL1 LYST NSMAF	1.72e-05	9	112	3	1.10.1540.10
Domain	Beach	NBEAL1 LYST NSMAF	1.72e-05	9	112	3	SM01026
Domain	-	CPS1 SYN1 SYN2	5.75e-05	13	112	3	3.40.50.20
Domain	PreATP-grasp_dom	CPS1 SYN1 SYN2	7.28e-05	14	112	3	IPR016185
Domain	-	CPS1 SYN1 SYN2	9.06e-05	15	112	3	3.30.1490.20
Domain	SYNAPSIN_1	SYN1 SYN2	1.07e-04	3	112	2	PS00415
Domain	SYNAPSIN_2	SYN1 SYN2	1.07e-04	3	112	2	PS00416
Domain	Synapsin_C	SYN1 SYN2	1.07e-04	3	112	2	PF02750
Domain	Synapsin_N	SYN1 SYN2	1.07e-04	3	112	2	PF10581
Domain	Synapsin_pre-ATP-grasp_dom	SYN1 SYN2	1.07e-04	3	112	2	IPR020897
Domain	Synapsin_ATP-bd_dom	SYN1 SYN2	1.07e-04	3	112	2	IPR020898
Domain	Synapsin_CS	SYN1 SYN2	1.07e-04	3	112	2	IPR019735
Domain	Synapsin_P_site	SYN1 SYN2	1.07e-04	3	112	2	IPR019736
Domain	Synapsin	SYN1 SYN2	1.07e-04	3	112	2	PF02078
Domain	Synapsin	SYN1 SYN2	1.07e-04	3	112	2	IPR001359
Domain	ATP_grasp_subdomain_1	CPS1 SYN1 SYN2	1.60e-04	18	112	3	IPR013815
Domain	-	CPS1 SYN1 SYN2	1.60e-04	18	112	3	3.30.470.20
Domain	ARM-type_fold	DOCK1 CEP104 STAG1 NBEAL1 MROH5 LYST SDAD1 RYR3 HEATR3	2.05e-04	339	112	9	IPR016024
Domain	WD40_repeat_dom	KNTC1 TBL1Y NBEAL1 VPS8 LYST WDHD1 NSMAF SON	4.24e-04	297	112	8	IPR017986
Domain	PH_BEACH	NBEAL1 LYST	5.26e-04	6	112	2	PF14844
Domain	ATP_grasp_subdomain_2	CPS1 SYN1 SYN2	8.35e-04	31	112	3	IPR013816
Domain	-	TBL1Y NBEAL1 VPS8 LYST WDHD1 NSMAF SON	3.95e-03	333	112	7	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	TBL1Y NBEAL1 VPS8 LYST WDHD1 NSMAF SON	4.08e-03	335	112	7	IPR015943
Domain	WD40_repeat	TBL1Y NBEAL1 VPS8 LYST WDHD1 NSMAF	5.97e-03	272	112	6	IPR001680
Pathway	REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION	TEAD1 TEAD4 TEAD3	2.64e-06	6	73	3	MM15544
Pathway	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION	TEAD1 TEAD4 TEAD3	7.32e-06	8	73	3	MM14816
Pathway	REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION	TEAD1 TEAD4 TEAD3	7.32e-06	8	73	3	M27823
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3	PSMB1 TEAD1 TEAD4 TEAD3 SMAD4	4.50e-05	76	73	5	MM15520
Pathway	REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION	TEAD1 TEAD4 TEAD3	5.80e-05	15	73	3	M603
Pathway	WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS	TEAD1 TEAD4 TEAD3	1.03e-04	18	73	3	M39421
Pathway	WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS	TEAD1 TEAD4 TEAD3	1.03e-04	18	73	3	M39825
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3	PSMB1 TEAD1 TEAD4 TEAD3 SMAD4	1.37e-04	96	73	5	M27784
Pathway	WP_HIPPOYAP_SIGNALING	TEAD1 TEAD4 TEAD3	1.91e-04	22	73	3	M39821
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	6.71e-20	68	114	13	11230163
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	1.50e-19	72	114	13	10380929
Pubmed	Maturation of postnatally generated olfactory bulb granule cells depends on functional γ-protocadherin expression.	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA12	1.56e-19	15	114	9	23515096
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	2.20e-19	74	114	13	10817752
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	3.84e-19	77	114	13	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	6.53e-19	80	114	13	10716726
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA12	2.07e-16	28	114	9	15347688
Pubmed	Functional significance of isoform diversification in the protocadherin gamma gene cluster.	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA12	1.55e-15	34	114	9	22884324
Pubmed	A differential developmental pattern of spinal interneuron apoptosis during synaptogenesis: insights from genetic analyses of the protocadherin-gamma gene cluster.	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA12	2.04e-14	44	114	9	19029045
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA12	2.50e-13	57	114	9	32633719
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CEP104 KNTC1 STAG1 PCDHGB2 PCDHGB1 HSPA4L PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PTGFR LYST SCCPDH DST PCDHGA12 AVIL PAEP SYNE2 PCDHGA8 ZNF292 ATP5F1C	9.30e-13	1442	114	26	35575683
Pubmed	A novel family of TEA domain-containing transcription factors with distinct spatiotemporal expression patterns.	TEAD1 TEAD4 TEAD3	3.43e-08	3	114	3	8920920
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHGB2 PCDHGA10 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3	3.83e-08	58	114	6	30377227
Pubmed	ISG12 is a critical modulator of innate immune responses in murine models of sepsis.	IFI27L2 IFI27 IFI27L1	1.37e-07	4	114	3	23747037
Pubmed	YAP/TEAD-mediated transcription controls cellular senescence.	TEAD1 TEAD4 TEAD3	1.37e-07	4	114	3	23576552
Pubmed	Localization of human transcription factor TEF-4 and TEF-5 (TEAD2, TEAD3) genes to chromosomes 19q13.3 and 6p21.2 using fluorescence in situ hybridization and radiation hybrid analysis.	TEAD1 TEAD4 TEAD3	1.37e-07	4	114	3	9889009
Pubmed	The TEA domain: a novel, highly conserved DNA-binding motif.	TEAD1 TEAD4 TEAD3	1.37e-07	4	114	3	2070413
Pubmed	A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain.	TEAD1 TEAD4 TEAD3	1.37e-07	4	114	3	8702974
Pubmed	Identification of a novel gene family that includes the interferon-inducible human genes 6-16 and ISG12.	IFI27L2 IFI27 IFI27L1	1.37e-07	4	114	3	14728724
Pubmed	Comparative expression analysis of TEADs and their splice variants in mouse embryonic stem cells.	TEAD1 TEAD4 TEAD3	1.37e-07	4	114	3	36516960
Pubmed	Transcription factor mTEAD-2 is selectively expressed at the beginning of zygotic gene expression in the mouse.	TEAD1 TEAD4 TEAD3	1.37e-07	4	114	3	9169843
Pubmed	VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle.	TEAD1 TEAD4 TEAD3	1.37e-07	4	114	3	31138678
Pubmed	TEAD mediates YAP-dependent gene induction and growth control.	TEAD1 TEAD4 TEAD3	3.41e-07	5	114	3	18579750
Pubmed	TONDU (TDU), a novel human protein related to the product of vestigial (vg) gene of Drosophila melanogaster interacts with vertebrate TEF factors and substitutes for Vg function in wing formation.	TEAD1 TEAD4 TEAD3	3.41e-07	5	114	3	10518497
Pubmed	Differential expression of the TEF family of transcription factors in the murine placenta and during differentiation of primary human trophoblasts in vitro.	TEAD1 TEAD4 TEAD3	3.41e-07	5	114	3	9671946
Pubmed	The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors.	IFI27L2 IFI27 IFI27L1	3.41e-07	5	114	3	22427340
Pubmed	Members of the TEAD family of transcription factors regulate the expression of Myf5 in ventral somitic compartments.	TEAD1 TEAD4 TEAD3	3.41e-07	5	114	3	21527258
Pubmed	Apoptotic properties of the type 1 interferon induced family of human mitochondrial membrane ISG12 proteins.	IFI27L2 IFI27 IFI27L1	3.41e-07	5	114	3	27673746
Pubmed	TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition.	TEAD1 TEAD4 TEAD3	3.41e-07	5	114	3	19324877
Pubmed	Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.	TEAD1 TEAD4 TEAD3	3.41e-07	5	114	3	22677547
Pubmed	The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation.	TEAD1 TEAD4 TEAD3	3.41e-07	5	114	3	20516196
Pubmed	Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.	TEAD1 TEAD4 TEAD3	6.81e-07	6	114	3	25995450
Pubmed	TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm.	TEAD1 TEAD4 TEAD3	6.81e-07	6	114	3	11358867
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	TET2 KNTC1 ING3 HSPA4L CASZ1 SALL1 BRD4 SYNE2 BRD9 ZNF292	8.14e-07	398	114	10	35016035
Pubmed	Differential expression of individual gamma-protocadherins during mouse brain development.	PCDHGA4 PCDHGA3 PCDHGA12	1.19e-06	7	114	3	15964765
Pubmed	Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3.	TEAD1 TEAD4 TEAD3	1.19e-06	7	114	3	14736747
Pubmed	Tead proteins activate the Foxa2 enhancer in the node in cooperation with a second factor.	TEAD1 TEAD4 TEAD3	1.19e-06	7	114	3	16207754
Pubmed	Transcription enhancer factor 1 binds multiple muscle MEF2 and A/T-rich elements during fast-to-slow skeletal muscle fiber type transitions.	TEAD1 TEAD4 TEAD3	1.19e-06	7	114	3	12861002
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	DOCK1 EHBP1 TET2 STAG1 TEAD1 KIAA1217 TLN2 CEP152 PEAK1 KLHL8 C1orf50	1.62e-06	536	114	11	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	DOCK1 EHBP1 TET2 STAG1 TEAD1 KIAA1217 TLN2 CEP152 PEAK1 KLHL8 C1orf50	1.68e-06	538	114	11	10512203
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	EHBP1 TET2 MLXIP LYST DNAH7 NHSL1 DST KIAA1217 BRD4 SYNE2 CEP152 PEAK1 GOLGA4	5.21e-06	861	114	13	36931259
Pubmed	Expression pattern of transcriptional enhanced associate domain family member 1 (Tead1) in developing mouse molar tooth.	TEAD1 TEAD4 TEAD3	9.58e-06	13	114	3	33984529
Pubmed	A mutation in the tuft mouse disrupts TET1 activity and alters the expression of genes that are crucial for neural tube closure.	TET2 GRHL2 PRICKLE2	9.58e-06	13	114	3	26989192
Pubmed	Seizure elements and seizure element transitions during tonic-clonic seizure activity in the synapsin I/II double knockout mouse: a neuroethological description.	SYN1 SYN2	1.07e-05	2	114	2	19236947
Pubmed	Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12.	IFI27L2 IFI27L1	1.07e-05	2	114	2	12388728
Pubmed	Synapsin I and Synapsin II regulate neurogenesis in the dentate gyrus of adult mice.	SYN1 SYN2	1.07e-05	2	114	2	29721159
Pubmed	The importance of synapsin I and II for neurotransmitter levels and vesicular storage in cholinergic, glutamatergic and GABAergic nerve terminals.	SYN1 SYN2	1.07e-05	2	114	2	19428802
Pubmed	A new kinetic framework for synaptic vesicle trafficking tested in synapsin knock-outs.	SYN1 SYN2	1.07e-05	2	114	2	21832187
Pubmed	Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.	UGT2B15 UGT2B17	1.07e-05	2	114	2	32660355
Pubmed	Electroencephalographic characterization of seizure activity in the synapsin I/II double knockout mouse.	SYN1 SYN2	1.07e-05	2	114	2	21281619
Pubmed	Synapsin-dependent development of glutamatergic synaptic vesicles and presynaptic plasticity in postnatal mouse brain.	SYN1 SYN2	1.07e-05	2	114	2	18606212
Pubmed	Glutamatergic neurotransmission in the synapsin I and II double knock-out mouse.	SYN1 SYN2	1.07e-05	2	114	2	21827868
Pubmed	Cloning of human RTEF-1, a transcriptional enhancer factor-1-related gene preferentially expressed in skeletal muscle: evidence for an ancient multigene family.	TEAD1 TEAD4	1.07e-05	2	114	2	8921372
Pubmed	Synapsins I and II are ATP-binding proteins with differential Ca2+ regulation.	SYN1 SYN2	1.07e-05	2	114	2	9430678
Pubmed	Synapsin dispersion and reclustering during synaptic activity.	SYN1 SYN2	1.07e-05	2	114	2	11685225
Pubmed	The Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific Manner.	IFI27L2 IFI27L1	1.07e-05	2	114	2	26699642
Pubmed	Synapsin II and calcium regulate vesicle docking and the cross-talk between vesicle pools at the mouse motor terminals.	SYN1 SYN2	1.07e-05	2	114	2	18669537
Pubmed	The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence.	UGT2B15 UGT2B17	1.07e-05	2	114	2	1909870
Pubmed	Synapsins regulate use-dependent synaptic plasticity in the calyx of Held by a Ca2+/calmodulin-dependent pathway.	SYN1 SYN2	1.07e-05	2	114	2	16481620
Pubmed	BRD9 regulates interferon-stimulated genes during macrophage activation via cooperation with BET protein BRD4.	BRD4 BRD9	1.07e-05	2	114	2	34983841
Pubmed	Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.	UGT2B15 UGT2B17	1.07e-05	2	114	2	24121496
Pubmed	Epileptogenic Q555X SYN1 mutant triggers imbalances in release dynamics and short-term plasticity.	SYN1 SYN2	1.07e-05	2	114	2	23406870
Pubmed	Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation.	UGT2B15 UGT2B17	1.07e-05	2	114	2	3117546
Pubmed	Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.	UGT2B15 UGT2B17	1.07e-05	2	114	2	24267955
Pubmed	The interferon-induced gene Ifi27l2a is active in lung macrophages and lymphocytes after influenza A infection but deletion of Ifi27l2a in mice does not increase susceptibility to infection.	IFI27L2 IFI27L1	1.07e-05	2	114	2	25184786
Pubmed	TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cells.	TET2 TOX2	1.07e-05	2	114	2	37467321
Pubmed	Deletion of synapsins I and II genes alters the size of vesicular pools and rabphilin phosphorylation.	SYN1 SYN2	1.07e-05	2	114	2	16844103
Pubmed	Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.	UGT2B15 UGT2B17	1.07e-05	2	114	2	22170718
Pubmed	Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment.	SYN1 SYN2	1.07e-05	2	114	2	18713831
Pubmed	Distinct changes in neuronal and astrocytic amino acid neurotransmitter metabolism in mice with reduced numbers of synaptic vesicles.	SYN1 SYN2	1.07e-05	2	114	2	18346203
Pubmed	TEAD transcription factors are required for normal primary myoblast differentiation in vitro and muscle regeneration in vivo.	TEAD1 TEAD4	1.07e-05	2	114	2	28178271
Pubmed	Long-term potentiation in mice lacking synapsins.	SYN1 SYN2	1.07e-05	2	114	2	8606805
Pubmed	Ultrastructural quantification of glutamate receptors at excitatory synapses in hippocampus of synapsin I+II double knock-out mice.	SYN1 SYN2	1.07e-05	2	114	2	16344150
Pubmed	Terminals of the major thalamic input to visual cortex are devoid of synapsin proteins.	SYN1 SYN2	1.07e-05	2	114	2	23535254
Pubmed	Synapsins: mosaics of shared and individual domains in a family of synaptic vesicle phosphoproteins.	SYN1 SYN2	1.07e-05	2	114	2	2506642
Pubmed	Absence of synapsin I and II is accompanied by decreases in vesicular transport of specific neurotransmitters.	SYN1 SYN2	1.07e-05	2	114	2	16478532
Pubmed	A delayed response enhancement during hippocampal presynaptic plasticity in mice.	SYN1 SYN2	1.07e-05	2	114	2	17569738
Pubmed	Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5.	UGT2B15 UGT2B17	1.07e-05	2	114	2	3105095
Pubmed	Synapsin utilization differs among functional classes of synapses on thalamocortical cells.	SYN1 SYN2	1.07e-05	2	114	2	16723536
Pubmed	UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.	UGT2B15 UGT2B17	1.07e-05	2	114	2	17848572
Pubmed	Synapsins I and II are not required for insulin secretion from mouse pancreatic β-cells.	SYN1 SYN2	1.07e-05	2	114	2	22334712
Pubmed	Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.	UGT2B15 UGT2B17	1.07e-05	2	114	2	27496708
Pubmed	Identification of ISG12b as a putative interferon-inducible adipocytokine which is highly expressed in white adipose tissue.	IFI27L2 IFI27L1	1.07e-05	2	114	2	17704618
Pubmed	Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation.	UGT2B15 UGT2B17	1.07e-05	2	114	2	28228532
Pubmed	Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.	CYP17A1 UGT2B17	1.07e-05	2	114	2	21919858
Pubmed	Interferon-stimulated gene ISG12b1 inhibits adipogenic differentiation and mitochondrial biogenesis in 3T3-L1 cells.	IFI27L2 IFI27L1	1.07e-05	2	114	2	18948406
Pubmed	Sensitive and critical periods in the development of handling induced seizures in mice lacking synapsins: differences between synapsin I and synapsin II knockouts.	SYN1 SYN2	1.07e-05	2	114	2	23570901
Pubmed	Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.	UGT2B15 UGT2B17	1.07e-05	2	114	2	15666817
Pubmed	TEAD1 and TEAD3 Play Redundant Roles in the Regulation of Human Epidermal Proliferation.	TEAD1 TEAD3	1.07e-05	2	114	2	32142794
Pubmed	Distinct roles of synapsin I and synapsin II during neuronal development.	SYN1 SYN2	1.07e-05	2	114	2	9513186
Pubmed	Synaptic vesicle phosphoproteins and regulation of synaptic function.	SYN1 SYN2	1.07e-05	2	114	2	8430330
Pubmed	The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.	UGT2B15 UGT2B17	1.07e-05	2	114	2	17698910
Pubmed	Human transcription factor protein interaction networks.	TET2 ZNF536 ING3 TBL1Y HSPA4L PSMB1 TEAD1 TEAD3 SDAD1 DST SALL1 SYNE2 BRD9 CEP152 ZNF687 ATP5F1C	1.76e-05	1429	114	16	35140242
Pubmed	Impaired learning in mice with abnormal short-lived plasticity.	SYN1 SYN2	3.19e-05	3	114	2	8939606
Pubmed	Synapsin selectively controls the mobility of resting pool vesicles at hippocampal terminals.	SYN1 SYN2	3.19e-05	3	114	2	22442064
Pubmed	Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.	UGT2B15 UGT2B17	3.19e-05	3	114	2	19572376
Pubmed	VGLL4-TEAD1 promotes vascular smooth muscle cell differentiation from human pluripotent stem cells via TET2.	TET2 TEAD1	3.19e-05	3	114	2	36657637
Pubmed	Synapsin condensation controls synaptic vesicle sequestering and dynamics.	SYN1 SYN2	3.19e-05	3	114	2	37872159
Pubmed	Synapsin IIa controls the reserve pool of glutamatergic synaptic vesicles.	SYN1 SYN2	3.19e-05	3	114	2	18945891
Pubmed	Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity.	TET2 BRD4	3.19e-05	3	114	2	29662175
Interaction	PCDHGA4 interactions	PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA12 PAEP PCDHGA8	1.36e-15	34	107	10	int:PCDHGA4
Interaction	PCDHGA12 interactions	PCDHGB2 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA4 PCDHGA12	4.01e-12	10	107	6	int:PCDHGA12
Interaction	PCDHGA9 interactions	PCDHGB2 PCDHGB1 PCDHGA9 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA12 PCDHGA8	6.02e-12	33	107	8	int:PCDHGA9
Interaction	H2BC5 interactions	ABCF1 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 VPS8 DST PCDHGA12 PCDHGA8	2.20e-11	331	107	16	int:H2BC5
Interaction	PCDHGA7 interactions	PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA12	4.33e-11	25	107	7	int:PCDHGA7
Interaction	PCDHGA8 interactions	PCDHGA9 PCDHGA5 PCDHGA4 PCDHGA8	3.74e-09	5	107	4	int:PCDHGA8
Interaction	PCDHA9 interactions	PCDHGB2 PCDHGA10 PCDHGA9 PCDHGA6 PCDHGA4 PCDHGA12	1.57e-08	32	107	6	int:PCDHA9
Interaction	PCDHGB2 interactions	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA6 PCDHGA12	1.17e-07	44	107	6	int:PCDHGB2
Interaction	PCDHGA6 interactions	PCDHGB2 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4	1.51e-07	24	107	5	int:PCDHGA6
Interaction	PCDHGA5 interactions	PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA8	1.03e-06	63	107	6	int:PCDHGA5
Interaction	PCDHGA10 interactions	PCDHGB2 PCDHGA10 PCDHGA7 PCDHGA4	2.74e-06	19	107	4	int:PCDHGA10
Interaction	PCDHGA3 interactions	PCDHGA9 PCDHGA4 PCDHGA3	1.19e-05	9	107	3	int:PCDHGA3
Interaction	PCDHGB1 interactions	PCDHGB2 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA12	5.60e-05	77	107	5	int:PCDHGB1
Interaction	PTGR1 interactions	FBP1 BRD4 FH ZNF687	7.20e-05	42	107	4	int:PTGR1
Interaction	VGLL1 interactions	TEAD1 TEAD4 TEAD3	9.37e-05	17	107	3	int:VGLL1
Interaction	LTBP1 interactions	PCDHGB2 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5	1.31e-04	92	107	5	int:LTBP1
Cytoband	5q31	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	2.66e-18	115	114	13	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	6.74e-13	298	114	13	chr5q31
Cytoband	16q12.1	ABCC11 SALL1 HEATR3	8.44e-05	34	114	3	16q12.1
Cytoband	4q13	UGT2B15 UGT2B17	6.28e-04	15	114	2	4q13
Cytoband	9q22	NFIL3 NINJ1	1.02e-03	19	114	2	9q22
Cytoband	Ensembl 112 genes in cytogenetic band chr9q22	COL15A1 FBP1 NFIL3 NINJ1	1.61e-03	200	114	4	chr9q22
Cytoband	Ensembl 112 genes in cytogenetic band chr16q12	ABCC11 SALL1 HEATR3	2.20e-03	103	114	3	chr16q12
Cytoband	14q32.12	IFI27L2 IFI27L1	2.38e-03	29	114	2	14q32.12
GeneFamily	Clustered protocadherins	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	5.78e-19	64	77	13	20
GeneFamily	TEA domain transcription factors	TEAD1 TEAD4 TEAD3	2.96e-07	4	77	3	1183
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL1 LYST NSMAF	6.13e-06	9	77	3	1230
GeneFamily	Synapsins	SYN1 SYN2	5.36e-05	3	77	2	1325
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 GBP1 IFI27 ANKRD44 SYNE2 GOLGA4 SON ZNF292	4.55e-08	200	113	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	IPF-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	IFI27L2 IFI27 ANKRD44 KIAA1217 PRICKLE2 SYN2 TOX2	6.99e-07	196	113	7	8f0f72ead06abe02b575e443552eacc2151077ef
ToppCell	Children_(3_yrs)-Epithelial-basal_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TBL1Y HSPA4L TTC6 KIAA1217 PRICKLE2 TNS4	6.27e-06	178	113	6	fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL15A1 PCDHGA5 PCDHGA4 TEAD3 TTC6 PDZRN3	6.48e-06	179	113	6	98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOCK1 GPR26 TEAD1 CLEC4F FBP1 DST	7.12e-06	182	113	6	c3fb1460160744144aa31afc76c0a4d42ebdeb91
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-C\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA4 PCDHGA2 PCDHGA1	7.58e-06	184	113	6	629cfed10e1112cf30f6a828ce9efbbc6b207789
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231\|Adult / Lineage, Cell type, age group and donor	IFI27 CASZ1 KIAA1217 PRICKLE2 SYN2 TOX2	7.82e-06	185	113	6	07f9f38f0739d7c830641723a38385550ac1ac92
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DOCK1 GRHL2 CASZ1 KIAA1217 PRICKLE2 PDZRN3	8.57e-06	188	113	6	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	IFI27 CASZ1 ANKRD44 KIAA1217 PRICKLE2 TOX2	9.10e-06	190	113	6	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	TEAD1 GRHL2 DNAH7 KIAA1217 SYNE2 PRICKLE2	1.06e-05	195	113	6	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	TEAD1 GRHL2 DNAH7 KIAA1217 SYNE2 PRICKLE2	1.06e-05	195	113	6	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	TEAD1 GRHL2 DNAH7 KIAA1217 SYNE2 PRICKLE2	1.06e-05	195	113	6	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	TEAD1 GRHL2 DNAH7 KIAA1217 SYNE2 PRICKLE2	1.09e-05	196	113	6	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	TEAD1 GRHL2 DNAH7 KIAA1217 SYNE2 PRICKLE2	1.09e-05	196	113	6	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	TEAD1 GRHL2 DNAH7 TTC6 KIAA1217 PRICKLE2	1.09e-05	196	113	6	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 STAG1 TEAD1 NHSL1 PRICKLE2 PEAK1	1.15e-05	198	113	6	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 GRHL2 PTGFR TTC6 NHSL1 KIAA1217	1.18e-05	199	113	6	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TET2 DST BRD4 SYNE2 GOLGA4 ZNF292	1.18e-05	199	113	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	COL15A1 PDGFRL PCDHGB2 PCDHGB1 PCDHGA10	1.75e-05	126	113	5	f1f24b06d301c266226d1a59dd28585f5ac68f29
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	COL15A1 PDGFRL PCDHGB2 PCDHGB1 PCDHGA10	1.75e-05	126	113	5	fe6900eb37e4f09465a1276586c73dd38545fa2a
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_TIP\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	COL15A1 PDGFRL PCDHGB2 PCDHGB1 PCDHGA10	1.75e-05	126	113	5	3d507f829882d043f633db2612b76936e2042445
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	COL15A1 PDGFRL PCDHGB2 PCDHGB1 PCDHGA10	1.75e-05	126	113	5	1ac4cc747e466bc79e33b97608b19ad29a7a6a41
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	COL15A1 PDGFRL PCDHGB2 PCDHGB1 PCDHGA10	1.75e-05	126	113	5	2de551d7a8765afec1da8852727c79fec90f45f8
ToppCell	Children_(3_yrs)-Epithelial-basal_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TBL1Y TTC6 KIAA1217 PRICKLE2 TNS4	5.03e-05	157	113	5	6ee2692f705bdd93ba523dffaf2f0cd921b47e28
ToppCell	facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 ANKRD44 CEP152 PARPBP ZNF292	5.03e-05	157	113	5	0fecc14959c4c9efc19d5c06475a890e0a30f148
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 RYR3 WDHD1 TLN2 KLHL8	5.34e-05	159	113	5	4000ed0d3b7d488722bcd0042fa2ff4405aaab82
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 RYR3 WDHD1 TLN2 KLHL8	5.34e-05	159	113	5	7619d0d49738dd08daf01b42664691a5323aa793
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANGPT2 GBP1 IFI27 CLEC4F TOX2	6.55e-05	166	113	5	ec719368295133da2f7ff587c5329ed6db1dd56d
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KNTC1 RYR3 WDHD1 TLN2 KLHL8	6.55e-05	166	113	5	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KNTC1 RYR3 WDHD1 TLN2 KLHL8	6.55e-05	166	113	5	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 HSPA4L PCDHGA2 GRHL2 NSMAF	6.74e-05	167	113	5	b742558ca92985db0a67c88f530bc375f3d3bb98
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TEAD3 TTC6 KIAA1217 SYNE2 PRICKLE2	7.33e-05	170	113	5	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EHBP1 IFI27L2 FANCM WDHD1 PARPBP	7.75e-05	172	113	5	ba36581ae339191a12a6d3ead39eaf69d78be10e
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCDHGA7 PCDHGA3 PCDHGA1 ANKRD44	8.16e-05	90	113	4	3817a5b0235e632d976ea565175bdbebbd959bf0
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCDHGA7 PCDHGA3 PCDHGA1 ANKRD44	8.16e-05	90	113	4	a528f5dcee1a356dea89ff2588d2e0f276f2d5fc
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZNF536 DST TLN2 PEAK1 PDZRN3	8.40e-05	175	113	5	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HSPA4L PCDHGA3 TTC6 KIAA1217 TNS4	8.87e-05	177	113	5	cbad1a23851151dbef01ea2af960e6f0944f838b
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HSPA4L PCDHGA3 TTC6 KIAA1217 TNS4	8.87e-05	177	113	5	ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL15A1 PDGFRL TEAD1 PTGFR OLFML1	9.10e-05	178	113	5	27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL15A1 PDGFRL TEAD1 PTGFR OLFML1	9.10e-05	178	113	5	d348a9550db940d204706529759dc51e30506b5f
ToppCell	T_cells-TFH-like_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	DOCK1 TEAD1 TTBK1 KIAA1217 TOX2	9.10e-05	178	113	5	e2ae43e5ec31de6197f2cbd6089f944adbf0a163
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHGA10 PCDHGA3 TEAD4 DST TLN2	9.35e-05	179	113	5	a09647750eba9d93c5efc1db3b555fefb5eec7b5
ToppCell	Epithelial-basal_cell\|World / Lineage, Cell type, age group and donor	HSPA4L GRHL2 TTC6 KIAA1217 TNS4	9.35e-05	179	113	5	d9be6647ec7b22747dc00dce4ea307b6af412dfa
ToppCell	COPD-Epithelial-Basal\|World / Disease state, Lineage and Cell class	TEAD1 GRHL2 TTC6 KIAA1217 TNS4	9.85e-05	181	113	5	6d8a886b4afe729f8a05b9c0f4ea9375de735da4
ToppCell	Control-Epithelial-Basal\|World / Disease state, Lineage and Cell class	TEAD3 GRHL2 TTC6 KIAA1217 TNS4	1.01e-04	182	113	5	759390dde9b18757f7675d13d44c89d0e32f8d93
ToppCell	Control-Epithelial-Basal\|Control / Disease state, Lineage and Cell class	TEAD3 GRHL2 TTC6 KIAA1217 TNS4	1.01e-04	182	113	5	caddd0a52f0234ea6a916186ffaf2454cdcd80ee
ToppCell	COPD-Epithelial-Basal\|COPD / Disease state, Lineage and Cell class	TEAD1 GRHL2 TTC6 KIAA1217 TNS4	1.04e-04	183	113	5	0f760e393edc91009bf6c7e02eeac039a1dfb4ed
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-3\|World / Primary Cells by Cluster	IFI27L2 ZNF536 ANGPT2 TOX2 PDZRN3	1.06e-04	184	113	5	907ba412166bcb0526c5be0b06a76b6bd37c5a35
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	CEP104 NBEAL1 MLXIP GOLGA4 ATP5F1C	1.06e-04	184	113	5	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	KNTC1 ITGAD ANKRD44 SEC63 ZNF292	1.12e-04	186	113	5	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANKRD44 SALL1 TLN2 NINJ1 SON	1.15e-04	187	113	5	ba822dbceb47257129d6a8c9639c08d76de6d6a3
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	TEAD4 KIAA1217 PRICKLE2 SYN2 TOX2	1.15e-04	187	113	5	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	ZNF536 COL15A1 DST TLN2 PDZRN3	1.15e-04	187	113	5	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	TBL1Y GRHL2 TTC6 KIAA1217 TNS4	1.15e-04	187	113	5	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IFI27 KIAA1217 PRICKLE2 SYN2 TOX2	1.18e-04	188	113	5	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GRHL2 PTGFR DNAH7 SCCPDH SYNE2	1.21e-04	189	113	5	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	KNTC1 CASZ1 WDHD1 CEP152 PARPBP	1.24e-04	190	113	5	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NHLRC2 SCCPDH PRICKLE2 TLN2 TOX2	1.27e-04	191	113	5	df8cdbc26443e55a203cbafa21b0952a2a55b9bf
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GRHL2 PTGFR TTC6 NHSL1 KIAA1217	1.27e-04	191	113	5	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron\|World / Primary Cells by Cluster	IFI27L2 ZNF536 ANGPT2 TOX2 PDZRN3	1.27e-04	191	113	5	4dd9c8117c4499ed9bde127baf2598603a82080d
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-tip_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	DOCK1 COL15A1 PCDHGA6 PCDHGA1 NHSL1	1.27e-04	191	113	5	cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL15A1 PDGFRL ABCC11 OLFML1 PDZRN3	1.27e-04	191	113	5	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	COL15A1 PDGFRL ABCC11 OLFML1 PDZRN3	1.27e-04	191	113	5	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TEAD1 GRHL2 PTGFR TTC6 KIAA1217	1.27e-04	191	113	5	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	368C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	GBP1 IFI27 SCCPDH FBP1 DST	1.30e-04	192	113	5	e1deb743b1f39b58a46b8df134e79d512a000273
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	TEAD1 GRHL2 TTC6 KIAA1217 PAEP	1.30e-04	192	113	5	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1\|World / Primary Cells by Cluster	IFI27L2 ZNF536 ANGPT2 TOX2 PDZRN3	1.30e-04	192	113	5	bcc499f4c7ba2898ecd9c47bf68c92ed359b81ba
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	TEAD1 GRHL2 PTGFR TTC6 KIAA1217	1.30e-04	192	113	5	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GRHL2 PTGFR TTC6 NHSL1 KIAA1217	1.30e-04	192	113	5	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	KNTC1 FANCM WDHD1 CEP152 PARPBP	1.33e-04	193	113	5	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	ZNF536 DST PRICKLE2 TLN2 PDZRN3	1.33e-04	193	113	5	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	KNTC1 ZNF536 WDHD1 CEP152 PARPBP	1.36e-04	194	113	5	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TEAD4 KIAA1217 PRICKLE2 SYN2 TOX2	1.36e-04	194	113	5	40842a7160f337bfc191ee15fbda3e3d38a04c57
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-3\|TCGA-Thymus / Sample_Type by Project: Shred V9	PCDHGB2 PCDHGA6 PCDHGA5 PCDHGA4	1.38e-04	103	113	4	91fe062dcadd12fdb04fa4593a794c57f3f0411d
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	TEAD1 GRHL2 KIAA1217 SYNE2 PRICKLE2	1.40e-04	195	113	5	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	TEAD1 GRHL2 KIAA1217 SYNE2 PRICKLE2	1.40e-04	195	113	5	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NHLRC2 SCCPDH PRICKLE2 TLN2 TOX2	1.40e-04	195	113	5	7e0ef92059ff34e368d2324815f49b50e3ca7332
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK1 COL15A1 PDGFRL RYR3 OLFML1	1.43e-04	196	113	5	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK1 COL15A1 PDGFRL RYR3 OLFML1	1.43e-04	196	113	5	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	ASK454-Endothelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	DOCK1 TEAD4 IFI27 CASZ1 TOX2	1.43e-04	196	113	5	14dd6956ef420b660be0baf52a66960e57d75d16
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL15A1 PTGFR SALL1 PRICKLE2 PDZRN3	1.43e-04	196	113	5	2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	COL15A1 TEAD1 DST PRICKLE2 PDZRN3	1.46e-04	197	113	5	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	COL15A1 ANGPT2 IFI27 CLEC4F SYNE2	1.46e-04	197	113	5	f969685dee212f33a6f09e54c0cd1fd24ffef546
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IFI27 KIAA1217 PRICKLE2 SYN2 TOX2	1.46e-04	197	113	5	81718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	GRHL2 TTC6 FBP1 SYNE2 SON	1.46e-04	197	113	5	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL15A1 ANGPT2 IFI27 CLEC4F SYNE2	1.46e-04	197	113	5	1a137af40697137bb9d2b5caf2b1ffda55f04461
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids\|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k)	IFI27L2 VPS8 SCCPDH FBP1 NINJ1	1.46e-04	197	113	5	c747d05bb032abf8dad46ff6f4d1951bbe64b3b4
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL15A1 ANGPT2 IFI27 CLEC4F SYNE2	1.46e-04	197	113	5	96d63a8d00583e2aa0a38412e2ae27e23f399493
ToppCell	Sigmoid-B_cell-B_cell_IgG_Plasma\|B_cell / Region, Cell class and subclass	TET2 PCDHGA9 RYR3 FBP1 PAEP	1.50e-04	198	113	5	305d7ae9b070ac7211638a5282374c02bf13af40
ToppCell	10x5'v1-week_12-13-Endothelial-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	DOCK1 COL15A1 PCDHGA2 PCDHGA1 NHSL1	1.50e-04	198	113	5	122215d9288533ad03562cf777e846504863df9a
ToppCell	390C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	NBEAL1 GBP1 IFI27 FBP1 FH	1.50e-04	198	113	5	8a4b4bb6839b9ec52ff0b9c7b39cec8d9a9525bd
ToppCell	10x5'v1-week_12-13-Endothelial\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	DOCK1 COL15A1 PCDHGA2 PCDHGA1 NHSL1	1.50e-04	198	113	5	307dd09e6bc820a148f3000f18dae7aedba4be0b
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NBEAL1 CPS1 GRHL2 FBP1 SYNE2	1.50e-04	198	113	5	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	Bronchial_Biopsy\|World / Tissue, Lineage and Cell class of Lung Cells from 10X	HSPA4L DST KIAA1217 SYNE2 TNS4	1.50e-04	198	113	5	f5b7013045b61fc56894f80092f799770dde1c8f
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GRHL2 PTGFR TTC6 NHSL1 KIAA1217	1.53e-04	199	113	5	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	BRD4 SYNE2 FH GOLGA4 ZNF292	1.53e-04	199	113	5	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	SCCPDH BRD4 SYNE2 SEC63 GOLGA4	1.53e-04	199	113	5	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	BRD4 SYNE2 FH GOLGA4 ZNF292	1.53e-04	199	113	5	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	CEP104 BRD4 SYNE2 GOLGA4 ZNF292	1.53e-04	199	113	5	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	BRD4 SYNE2 FH GOLGA4 ZNF292	1.53e-04	199	113	5	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
Drug	CID9959010	PCDHGA10 PCDHGA3 PCDHGA2 RYR3 PCDHGA12 PCDHGA8	3.54e-08	39	112	6	CID009959010
Drug	montmorillonite	PCDHGA10 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8	1.51e-06	40	112	5	CID000517273
Drug	AC1L7AJI	HSPA4L PCDHGA10 PCDHGA3 PCDHGA2 IFI27 PCDHGA12 UGT2B15 UGT2B17 PCDHGA8	5.01e-06	256	112	9	CID000003750
Drug	AC1L1UVI	PCDHGA10 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8	7.53e-06	55	112	5	CID000061263
Disease	mental development measurement	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA8	2.17e-23	25	111	12	EFO_0008230
Disease	Sarcosine measurement	PCDHGB2 PCDHGB1 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA8	4.11e-19	23	111	10	EFO_0021668
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 PCDHGA12 PCDHGA8	7.08e-19	71	111	13	EFO_0007878, EFO_0007979
Disease	lymphocyte count	TET2 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 NHLRC2 CPS1 GRHL2 LYST CASZ1 PCDHGA12 SYN2 PCDHGA8 NSMAF	1.13e-07	1464	111	21	EFO_0004587
Disease	mean platelet volume	TET2 PCDHGB2 PCDHGB1 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 CPS1 PCDHGA12 SYNE2 KLHL8 PCDHGA8	2.71e-07	1020	111	17	EFO_0004584
Disease	cholic acid glucuronide measurement	UGT2B15 UGT2B17	4.20e-05	3	111	2	EFO_0800574
Disease	X-25937 measurement	UGT2B15 UGT2B17	8.37e-05	4	111	2	EFO_0800937
Disease	Chediak-Higashi syndrome (implicated_via_orthology)	LYST NSMAF	8.37e-05	4	111	2	DOID:2935 (implicated_via_orthology)
Disease	Prostatic Neoplasms	EHBP1 TET2 COL15A1 CYP17A1 CASZ1 BRD4 UGT2B15 UGT2B17 GOLGA4 ZNF292	1.14e-04	616	111	10	C0033578
Disease	Malignant neoplasm of prostate	EHBP1 TET2 COL15A1 CYP17A1 CASZ1 BRD4 UGT2B15 UGT2B17 GOLGA4 ZNF292	1.14e-04	616	111	10	C0376358
Disease	L-arginine measurement, amino acid measurement	PDGFRL CPS1	1.39e-04	5	111	2	EFO_0005134, EFO_0006524
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	NHLRC2 CPS1 TEAD3 UGT2B15 SYN2 UGT2B17 KLHL8	2.18e-04	321	111	7	EFO_0004612, EFO_0004639
Disease	bilirubin measurement	ING3 STAG1 MLXIP CPS1 NFIL3 UGT2B15 SYN2 KLHL8	2.74e-04	442	111	8	EFO_0004570
Disease	X-24574 measurement	UGT2B15 UGT2B17	2.91e-04	7	111	2	EFO_0800897
Disease	Alzheimer disease, polygenic risk score	FOXN2 PCDHGB2 PCDHGB1 PCDHGA5 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA1 DST	3.79e-04	586	111	9	EFO_0030082, MONDO_0004975
Disease	deoxycholic acid glucuronide measurement	UGT2B15 UGT2B17	3.87e-04	8	111	2	EFO_0800575
Disease	Abnormality of the face	BRD4 ZNF292	4.96e-04	9	111	2	C4025871
Disease	IGF-1 measurement	ZNF536 STAG1 SALL1 SYNE2 UGT2B15 UGT2B17 PARPBP NSMAF	5.28e-04	488	111	8	EFO_0004627
Disease	4-androsten-3alpha,17alpha-diol monosulfate (3) measurement	UGT2B15 UGT2B17	6.19e-04	10	111	2	EFO_0022090
Disease	serum gamma-glutamyl transferase measurement	EHBP1 FOXN2 STAG1 CPS1 SALL1 UGT2B15 SYN2 KLHL8 GOLGA4 NSMAF ZNF292	6.72e-04	914	111	11	EFO_0004532
Disease	DNA repair protein RAD51 homolog 4 measurement	UGT2B15 UGT2B17	7.54e-04	11	111	2	EFO_0801531
Disease	5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement	UGT2B15 UGT2B17	9.03e-04	12	111	2	EFO_0800291
Disease	androstenediol (3alpha, 17alpha) monosulfate (3) measurement	UGT2B15 UGT2B17	1.06e-03	13	111	2	EFO_0800293
Disease	X-19141 measurement	UGT2B15 UGT2B17	1.06e-03	13	111	2	EFO_0800799
Disease	phenylalanine measurement	CPS1 WDHD1 PARPBP	1.18e-03	55	111	3	EFO_0005001
Disease	5alpha-androstan-3alpha,17alpha-diol monosulfate measurement	UGT2B15 UGT2B17	1.24e-03	14	111	2	EFO_0800283
Disease	lipid measurement, high density lipoprotein cholesterol measurement	NHLRC2 CPS1 TEAD3 UGT2B15 SYN2 UGT2B17	1.58e-03	330	111	6	EFO_0004529, EFO_0004612
Disease	dual specificity mitogen-activated protein kinase kinase 2 measurement	IFI27 IFI27L1	1.63e-03	16	111	2	EFO_0008112
Disease	obsolete_red blood cell distribution width	EHBP1 PCDHGA5 PEX12 CPS1 ITGAD KIAA1217 BRD4 SYNE2 BRD9 UGT2B15 SYN2 TOX2 HEATR3	1.67e-03	1347	111	13	EFO_0005192
Disease	transitional cell carcinoma (is_marker_for)	ANGPT2 BRD4 SMAD4	1.75e-03	63	111	3	DOID:2671 (is_marker_for)
Disease	protein Z-dependent protease inhibitor measurement	IFI27 IFI27L1	2.06e-03	18	111	2	EFO_0021849
Disease	5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement	UGT2B15 UGT2B17	2.06e-03	18	111	2	EFO_0800288
Disease	congenital heart disease (implicated_via_orthology)	USP17L4 USP17L8 SON	2.27e-03	69	111	3	DOID:1682 (implicated_via_orthology)
Disease	etiocholanolone glucuronide measurement	UGT2B15 UGT2B17	2.30e-03	19	111	2	EFO_0800362
Disease	androsterone glucuronide measurement	UGT2B15 UGT2B17	2.55e-03	20	111	2	EFO_0800317
Disease	glucagon measurement	TET2 ZNF536 SCCPDH NSMAF	2.77e-03	154	111	4	EFO_0008463
Disease	cerebellar cortex volume measurement	CPS1 TTC6	2.81e-03	21	111	2	EFO_0010291
Disease	mean corpuscular hemoglobin concentration	KNTC1 HSPA4L PCDHGA5 C16orf96 CPS1 WDHD1 KIAA1217 BRD4 SYN2 TOX2 HEATR3	3.02e-03	1105	111	11	EFO_0004528
Disease	X-24947 measurement	UGT2B15 UGT2B17	3.08e-03	22	111	2	EFO_0800910
Disease	pulmonary hypertension (biomarker_via_orthology)	ANGPT2 RYR3 SMAD4	3.45e-03	80	111	3	DOID:6432 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
MSSRQAMLENASDIK	ABCF1	291	Q8NE71
MRITADMKNATLSLN	AVIL	736	O75366
AMSANMNKALQEELT	CEP152	461	O94986
MAATIDMNFQSDLLS	BRD4	1341	O60885
MMSKQAALLGNEDTA	BRD9	236	Q9H8M2
SSLLSSLMNKMSQGN	CASZ1	951	Q86V15
NNLLTMMSTSNSAKD	ANGPT2	256	O15123
SRAVLMKDNDKNMST	NBEAL1	1286	Q6ZS30
NTKMTQTPESMLLAA	ERVK-16	66	P61578
AQSQMSLVSMCKDLS	PDZRN3	896	Q9UPQ7
SNATDLLRKMATQMV	RBM45	326	Q8IUH3
EMLQAMILASASEAA	PCDHGA7	846	Q9Y5G6
EMLQAMILASASEAA	PCDHGA2	846	Q9Y5H1
NSLLFMETSAKTAMN	RAB5C	156	P51148
MLQAMILASASEAAD	PCDHGA5	846	Q9Y5G8
EMLQAMILASASEAA	PCDHGA8	846	Q9Y5G5
SMLLALQLSMAENNK	PARPBP	36	Q9NWS1
EMLQAMILASASEAA	PCDHGA12	846	O60330
EMLQAMILASASEAA	PCDHGA4	876	Q9Y5G9
AMATNNISLMATLKA	PAEP	41	P09466
IASSSIAAKMMSAAA	IFI27	61	P40305
EMLQAMILASASEAA	PCDHGA6	846	Q9Y5G7
AGIAASSIAAKMMSA	IFI27L2	31	Q9H2X8
SSIAAKMMSAAAIAN	IFI27L2	36	Q9H2X8
MAVQESAAQLSMTLK	MAEA	1	Q7L5Y9
AKMLEMAQANSAGIS	GOLGA4	1001	Q13439
IALTTKENNSGMNSM	IBTK	1161	Q9P2D0
ASNDNANKTCKMMLA	DST	5226	Q03001
SVKRMANSSLQEISM	FANCM	1996	Q8IYD8
TSARMSAAEMLKNTD	NHSL1	1436	Q5SYE7
DTFLAANSMLSMAAL	GPR26	86	Q8NDV2
TMAAAQAVQATAQMK	ING3	226	Q9NXR8
MSMNNSKQLVSPAAA	PTGFR	1	P43088
MASDSMSSKQARNHI	KLHL8	1	Q9P2G9
EMLQAMILASASEAA	PCDHGA9	846	Q9Y5G4
MLQAMILASASEAAD	PCDHGA10	851	Q9Y5H3
EMLQAMILASASEAA	PCDHGB1	841	Q9Y5G3
MLQAMILASASEAAD	PCDHGB2	846	Q9Y5G2
DLQKSMESSLCVMAN	PEAK1	1171	Q9H792
LDASSNVDKMMVLNS	NFIL3	16	Q16649
KLTASMAFSMLASLN	ABCC11	411	Q96J66
VKMLESLLNSMSASV	KNTC1	581	P50748
AESAQASAKMLQEMQ	GBP1	496	P32455
IAASSIAAKMMSTAA	IFI27L1	41	Q96BM0
NAVDNSGKTALMMAA	ANKRD44	866	Q8N8A2
MSNNIALLKTDTAMH	PRSS54	126	Q6PEW0
ADSSACMMKAILFSQ	NHLRC2	691	Q8NBF2
LLNASCDNMLMGIKS	OLFML1	136	Q6UWY5
NSSVAAPMMVSNILK	MED14	1406	O60244
SAAESMLDIALLMAN	NINJ1	46	Q92982
MLMRASASSENNKAS	ITGAD	891	Q13349
VMMSNKLSAQLLSIS	OR5AC2	136	Q9NZP5
EMLQAMILASASEAA	PCDHGA3	846	Q9Y5H0
MNVSEKLSNMGTLNS	PRICKLE2	581	Q7Z3G6
VLSNDLVMNMLKSSF	FBP1	76	P09467
KMCFDMLNSLISNNS	MLXIP	736	Q9HAP2
LMDLSTKAFAMTNQI	CPS1	606	P31327
KANSSVHLAMSQMGL	CEP104	576	O60308
ALLQTMASKNISQCM	HEATR3	521	Q7Z4Q2
ENPLTAATKAMMSIN	GRHL2	41	Q6ISB3
KLSFSMQSSLELNGM	DOCK1	1776	Q14185
PALSQAMVATKQAMS	C16orf96	661	A6NNT2
GAMNTTACSLMKIAN	FH	326	P07954
SDSITNMLDTLMQAK	CYP17A1	256	P05093
AAIKDNCASMNLQMT	DNAH7	1571	Q8WXX0
MAQKPLSTAAAERMN	C20orf85	1	Q9H1P6
SLASLMSMKQADIGN	EHBP1	171	Q8NDI1
AQTESLLMKMRSVAN	LYST	2601	Q99698
SDIDAAAAMMLLNTS	FOXN2	236	P32314
SKMLQRSISFSNMAL	NSMAF	661	Q92636
SARMTAMDNASKNAS	ATP5F1C	251	P36542
TAFSNMDDMLQKAHL	COL15A1	1136	P39059
SSIAALENQMKMINA	SALL1	861	Q9NSC2
SNNKAMTTGAIAAML	PSMB1	106	P20618
AKISMMDTLLSQSVA	C1orf50	171	Q9BV19
SLSQAAMMQSALAKE	DHX8	471	Q14562
MLQAMILASASEAAD	PCDHGA1	846	Q9Y5H4
SAATGFKMLQDMNSA	MROH5	86	Q6ZUA9
MQMADAATIATMNKA	RXFP3	1	Q9NSD7
KTNTGSAMLEQIAMS	SYN1	336	P17600
KTNTGSAMLEQIAMS	SYN2	336	Q92777
NKDSAVEMAMSKQLS	SYNE2	2406	Q8WXH0
IAMVQAAMTLLSDAS	SCCPDH	376	Q8NBX0
LTLQSNAPSSMMVKD	SMAD4	146	Q13485
MKENSISNMSLLRDS	KIAA1217	1241	Q5T5P2
SEALKSLTMQVLNSM	VPS8	1166	Q8N3P4
DSNATAAKMSLDVMI	SDAD1	171	Q9NVU7
DSANSAPKTQSIMMQ	PDGFRL	56	Q15198
AKASMMQQPARSVSE	PEX12	216	O00623
GMKNASALTSQTQML	CLEC4F	396	Q8N1N0
MQCLAAALKDETNMS	TTBK1	1	Q5TCY1
NFAAMQDINAAMKIS	TTC6	331	Q86TZ1
LLNLSSMNSTDQESM	USP17L4	486	A6NCW7
SQAELAQSTMSMRKK	TNS4	126	Q8IZW8
FMNDLDVSSKMNRAQ	HSPA4L	291	O95757
NELMQALNMSAALTA	RYR3	1846	Q15413
KEPAMSMNSARSTNI	WDHD1	921	O75717
QVSKDKALQSMASMS	TEAD3	116	Q99594
KALQSMASMSSAQIV	TEAD3	121	Q99594
LKTENGDSQMMALNS	ZNF292	1721	O60281
ASLENCMKLSQMAVQ	SEC63	361	Q9UGP8
TSTLAAMKLMTALVN	STAG1	221	Q8WVM7
AATEASAMAKAATMT	TBL1Y	111	Q9BQ87
AAKDKALQSMAAMSS	TEAD4	121	Q15561
ALQSMAAMSSAQIIS	TEAD4	126	Q15561
SNMISSLDSASEKMA	ZNF536	1066	O15090
AMLASHMSALSQSQL	TOX2	171	Q96NM4
LMSLAKAVANAAAML	TLN2	671	Q9Y4G6
LLNLSSMNSTDQESM	USP17L8	486	P0C7I0
IQNASTAMLMAASVA	ZNF687	406	Q8N1G0
AFNSHNKSLLTIMMS	TAPT1	266	Q6NXT6
NMSEESANMIASALA	UGT2B15	316	P54855
DKALQHMAAMSSAQI	TEAD1	116	P28347
ENDMLSHTANGLSKM	TET2	1786	Q6N021
LASNTMDSQMLASNT	SON	726	P18583
LASNTMDSQMLASNT	SON	736	P18583
QMVKSANMNGLLDSD	PPIP5K1	606	Q6PFW1
NMSEESANMIASALA	UGT2B17	316	O75795
QSLMLMATSNEGSKA	TRBV20-1	56	A0A075B6N2